Journal Article

Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia

Patel, Jaymin C., Kong, Nareth, Thamnurak, Chatchadaporn, Huy, Rekol, Thay, Kheang Heng, Wojnarski, Mariusz, Juliano, Jonathan J., Chann, Soklyda, Sundrakes, Siratchana, Chattrakarn, Sorayut, Lon, Chanthap, Lin, Jessica, Saunders, David L., Chaorattanakawee, Suwanna, You, Yom, Praditpol, Chantida, Lanteri, Charlotte A., Spring, Michele D., Yingyuen, Kritsanai, Walsh, Douglas S.

2017

Overview

Background While intensive Plasmodium falciparum multidrug resistance surveillance continues in Cambodia, relatively little is known about Plasmodium vivax drug resistance in Cambodia or elsewhere. To investigate P. vivax anti-malarial susceptibility in Cambodia, 76 fresh P. vivax isolates collected from Oddar Meanchey (northern Cambodia) in 2013–2015 were assessed for ex vivo drug susceptibility using the microscopy-based schizont maturation test (SMT) and a Plasmodium pan-species lactate dehydrogenase (pLDH) ELISA. P. vivax multidrug resistance gene 1 ( pvmdr1 ) mutations, and copy number were analysed in a subset of isolates. Results Ex vivo testing was interpretable in 80% of isolates using the pLDH-ELISA, but only 25% with the SMT. Plasmodium vivax drug susceptibility by pLDH-ELISA was directly compared with 58 P. falciparum isolates collected from the same locations in 2013–4, tested by histidine-rich protein-2 ELISA. Median pLDH-ELISA IC 50 of P. vivax isolates was significantly lower for dihydroartemisinin (3.4 vs 6.3 nM), artesunate (3.2 vs 5.7 nM), and chloroquine (22.1 vs 103.8 nM) than P. falciparum but higher for mefloquine (92 vs 66 nM). There were not significant differences for lumefantrine or doxycycline. Both P. vivax and P. falciparum had comparable median piperaquine IC 50 (106.5 vs 123.8 nM), but some P. falciparum isolates were able to grow in much higher concentrations above the normal standard range used, attaining up to 100-fold greater IC 50 s than P. vivax . A high percentage of P. vivax isolates had pvmdr1 Y976F (78%) and F1076L (83%) mutations but none had pvmdr1 amplification. Conclusion The findings of high P. vivax IC 50 to mefloquine and piperaquine, but not chloroquine, suggest significant drug pressure from drugs used to treat multidrug resistant P. falciparum in Cambodia. Plasmodium vivax isolates are frequently exposed to mefloquine and piperaquine due to mixed infections and the long elimination half-life of these drugs. Difficulty distinguishing infection due to relapsing hypnozoites versus blood-stage recrudescence complicates clinical detection of P. vivax resistance, while well-validated molecular markers of chloroquine resistance remain elusive. The pLDH assay may be a useful adjunctive tool for monitoring for emerging drug resistance, though more thorough validation is needed. Given high grade clinical chloroquine resistance observed recently in neighbouring countries, low chloroquine IC 50 values seen here should not be interpreted as susceptibility in the absence of clinical data. Incorporating pLDH monitoring with therapeutic efficacy studies for individuals with P. vivax will help to further validate this field-expedient method.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Analysis / Antimalarials - pharmacology / Artesunate / Biomedical and Life Sciences / Biomedicine / Cambodia / Care and treatment / Chloroquine / Copy number / Dehydrogenases / Dihydroartemisinin / DNA Copy Number Variations / Doxycycline / Drug Resistance / Drugs / ELISA / Entomology / Enzyme-linked immunosorbent assay / Enzyme-Linked Immunosorbent Assay - methods / Erythrocytes / Ex vivo assay / Histidine / Infections / Infectious Diseases / L-Lactate dehydrogenase / L-Lactate Dehydrogenase - genetics / L-Lactate Dehydrogenase - metabolism / Lactate / Lactic acid / Malaria / Measurement / Mefloquine / Microbiology / Microscopy / Microscopy - methods / Multidrug resistance / Multidrug Resistance-Associated Proteins - genetics / Multidrug Resistance-Associated Proteins - metabolism / Mutation / Parasites / Parasitology / Physiological aspects / Plasmodium falciparum / Plasmodium vivax / Plasmodium vivax - drug effects / Protozoan Proteins - genetics / Protozoan Proteins - metabolism / Public Health / pvmdr1 / Schizonts - growth & development / Surveillance / Tropical Medicine